Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Julphar
Accenture
Medtronic
Covington
Express Scripts
Daiichi Sankyo
Chinese Patent Office
Mallinckrodt
Baxter

Generated: August 20, 2017

DrugPatentWatch Database Preview

AFINITOR Drug Profile

« Back to Dashboard

What is the patent landscape for Afinitor, and when can generic versions of Afinitor launch?

Afinitor is a drug marketed by Novartis and Novartis Pharm and is included in two NDAs. There are nine patents protecting this drug and three Paragraph IV challenges.

This drug has one hundred and five patent family members in thirty-nine countries.

The generic ingredient in AFINITOR is everolimus. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the everolimus profile page.

Summary for Tradename: AFINITOR

Patents:8
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list15
Clinical Trials: see list146
Patent Applications: see list7,807
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AFINITOR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharm
AFINITOR DISPERZ
everolimus
TABLET, FOR SUSPENSION;ORAL203985-002Aug 29, 2012RXYesNo► Subscribe► SubscribeY► Subscribe
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-004Mar 30, 2012RXYesNo► Subscribe► Subscribe► Subscribe
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-001Mar 30, 2009RXYesNo► Subscribe► Subscribe► Subscribe
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-002Mar 30, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-002Mar 30, 2009RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: AFINITOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-003Jul 9, 2010► Subscribe► Subscribe
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-001Mar 30, 2009► Subscribe► Subscribe
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-004Mar 30, 2012► Subscribe► Subscribe
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-002Mar 30, 2009► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: AFINITOR

Drugname Dosage Strength RLD Submissiondate
everolimusTablets for Oral Suspension2 mg, 3 mg and 5 mgAfinitor Disperz12/30/2016
everolimusTablets2.5 mg, 5 mg, and 7.5 mgAfinitor12/10/2014
everolimusTablets10 mgAfinitor6/18/2014

Non-Orange Book Patents for Tradename: AFINITOR

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,605,613 Macrolides► Subscribe
7,572,804Macrolides► Subscribe
6,852,729 Macrolides► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: AFINITOR

Country Document Number Estimated Expiration
Czech Republic303006► Subscribe
CroatiaP20140708► Subscribe
European Patent Office2275103► Subscribe
United Kingdom0609912► Subscribe
Spain2288033► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Teva
Federal Trade Commission
Cantor Fitzgerald
Chinese Patent Office
Mallinckrodt
Fish and Richardson
Johnson and Johnson
Healthtrust
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot